Four Alternatives to Harmo Brain: Which Formula Matches the Research?

Harmo Brain contains three ingredients at transparent doses with independent peer-reviewed RCTs. Four alternatives dominate the market. Only two match Harmo Brain on label transparency. None match it on dose-to-evidence alignment for adults over 50. This comparison breaks down each label line by line.

Written and fact-checked by RecallPath Editorial Team. Last updated: August 31, 2026. About our editorial process.

Neuriva Original: 100 mg coffee cherry extract + 100 mg phosphatidylserine. One industry-sponsored trial (n=138, 42 days). Soy-derived PS at one-third the studied dose.
Focus Factor Original: Proprietary blend with vinpocetine (FDA warning for fetal harm). No independent RCT on the formula. Doses hidden.
Alpha Brain: Proprietary blends. One company-funded trial in adults aged 18-35 (n=63). Bacopa at one-third the studied dose. Vinpocetine removed from current formula.
MindVault: 250 mg citicoline + 100 mg phosphatidylserine + 200 mg rhodiola + 500 mcg B12. Transparent label. Per-ingredient RCTs.

Four supplement bottles arranged on a white surface showing different labels

At a glance

Alternative	Label	Key Actives	Evidence	Best For
Neuriva Original	Transparent	100 mg WCCE + 100 mg PS	1 industry trial (n=138, 42 days)	Adults 40-65 with self-reported memory concerns
Focus Factor Original	Proprietary blend	14 ingredients in 641 mg blend	No formula RCT	General multivitamin + nootropic stack
Alpha Brain	Proprietary blends	Alpha-GPC, bacopa 100 mg, Huperzine A	1 trial in adults 18-35 (n=63)	Younger adults seeking recall support
MindVault	Transparent	250 mg citicoline + 100 mg PS + 200 mg rhodiola + 500 mcg B12	Per-ingredient RCTs	Adults 50+ seeking broader cognitive support

Neuriva Original

Neuriva Original contains two active ingredients: 100 mg of whole coffee cherry extract (Neurofactor) and 100 mg of phosphatidylserine per capsule. The label is transparent. There is no proprietary blend.

The clinical evidence comes from one industry-sponsored trial by Doma et al. (Neurology and Therapy, 2023, PMC10195946). It was a randomized, double-blind, placebo-controlled study of 138 healthy adults aged 40 to 65 with self-reported memory problems. Participants took Neuriva or placebo daily for 42 days. The primary outcomes were plasma BDNF levels and COMPASS cognitive test scores. The trial reported improvements in some cognitive measures, but it was funded by the manufacturer (Schiff Vitamins) and lasted only six weeks.

Phosphatidylserine has an FDA qualified health claim from 2003: “Very limited and preliminary scientific research suggests that phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly. FDA concludes that there is little scientific evidence supporting this claim.” The PS dose in Neuriva is 100 mg. Most PS studies for cognitive decline used 300 mg daily, often divided into three doses. Neuriva uses soy-derived PS, while the majority of published PS trials used bovine-derived PS. The evidence for soy-derived PS is more sparse.

Neuriva contains no citicoline, no bacopa monnieri and no B12. It is a two-ingredient formula centered on BDNF signaling and membrane support. For adults over 50, the lack of cholinergic support and the short trial duration are notable gaps.

Focus Factor Original

Focus Factor Original combines a multivitamin base with a 641 mg proprietary blend of nootropic ingredients. The blend includes bacopa monnieri, phosphatidylserine, DHA, L-tyrosine, bilberry fruit extract, GABA, grape skin and seed extracts, vinpocetine, Huperzine A, boron citrate and vanadium. The exact dose of each ingredient inside the 641 mg blend is not disclosed.

Innerbody Research analyzed the blend and concluded that the total mass is insufficient to contain effective doses of the key nootropic ingredients. To include the studied amounts of just bacopa monnieri, phosphatidylserine and L-tyrosine would require more than 641 mg. The proprietary blend structure obscures this.

Vinpocetine is the most concerning ingredient. The FDA stated in 2016 that vinpocetine does not meet the definition of a dietary ingredient. In 2019, the FDA warned that vinpocetine may cause fetal harm and miscarriage. The agency advised companies marketing vinpocetine-containing supplements to include safety warnings for pregnant women and women who could become pregnant. Focus Factor still contains vinpocetine.

There is no independent peer-reviewed RCT on the Focus Factor formula. The company references a clinical study, but it was not published in a peer-reviewed journal with full methodology available for independent scrutiny. The serving size is four hard tablets daily, which raises absorption concerns compared to capsules or softgels.

Alpha Brain

Alpha Brain uses three proprietary blends: Onnit Flow Blend (650 mg), Onnit Focus Blend (240 mg) and Onnit Fuel Blend (65 mg). The Flow Blend contains L-tyrosine, L-theanine, oat straw extract and phosphatidylserine. The Focus Blend contains alpha-GPC, bacopa monnieri extract and Huperzia serrata (providing Huperzine A). The Fuel Blend contains L-leucine and pterostilbene.

The clinical evidence is a single company-funded trial by Solomon et al. (Journal of the International Society of Sports Nutrition, 2015, PMC4595564). It randomized 63 treatment-naive healthy adults aged 18 to 35 to Alpha Brain or placebo for six weeks. The Alpha Brain group showed significant improvement in delayed verbal recall and executive functioning compared to placebo (p < 0.05). However, the sample was small, the population was young adults, and the trial was sponsored by the manufacturer (Onnit Labs).

ConsumerLab notes that vinpocetine was present in the Alpha Brain formula tested in the 2015 trial, but it has since been removed from the commercial product. This means the current formula has not been tested in any published clinical trial. The bacopa dose in Alpha Brain is approximately 100 mg, which is one-third of the 300 mg dose used in the Stough et al. (Psychopharmacology, 2001) memory trial. Oat straw extract and cat’s claw have no published human trials showing memory or cognitive benefits.

MindVault

MindVault is the closest structural match to Harmo Brain among the four alternatives. It contains 250 mg citicoline, 100 mg phosphatidylserine, 200 mg rhodiola rosea extract and 500 mcg vitamin B12. The label is fully transparent. There is no proprietary blend.

The citicoline and phosphatidylserine doses overlap with Harmo Brain, but MindVault replaces bacopa with rhodiola and adds B12. Rhodiola has human data on mental fatigue under stress. The B12 dose addresses the deficiency common after age 60. For a full breakdown, see our MindVault review.

What to look for on the label

Transparent doses beat proprietary blends every time. Look for standardized extracts (bacopa monnieri at 300 mg with at least 55% bacosides). Check for third-party testing seals (USP, NSF). Avoid formulas with vinpocetine or other FDA-flagged ingredients. Match the dose to the published RCT, not the marketing claim.

Safety notes

Neuriva warnings

Phosphatidylserine has a theoretical bleeding risk. It can interact with warfarin, aspirin and other anticoagulants. Whole coffee cherry extract contains negligible caffeine (less than 4 mg per dose), but long-term safety data is limited. Avoid during pregnancy without physician consultation.

Focus Factor warnings

Vinpocetine may cause fetal harm and miscarriage. Do not use if pregnant or planning pregnancy. Huperzine A is a potent cholinesterase inhibitor. Overdose can cause nausea, vomiting, diarrhea, dizziness and muscle weakness. The proprietary blend makes it impossible to know how much Huperzine A is in each serving.

Alpha Brain warnings

Huperzine A can cause headache, nausea, dizziness and insomnia. Bacopa monnieri may cause gastrointestinal upset in some users. The current formula has not been tested in published clinical trials. Start with one capsule to assess tolerance.

MindVault warnings

Rhodiola rosea can affect thyroid hormone levels. Avoid if you have hyperthyroidism, hypothyroidism or take thyroid medication. Citicoline is a cholinergic. Some users report headache or difficulty sleeping, especially if taken late in the day. Phosphatidylserine has a theoretical bleeding risk.

The bottom line

Harmo Brain remains the only formula in this group where every active ingredient is dosed at or near a published peer-reviewed RCT level for adults over 50, with full label transparency and no proprietary blend.

Neuriva offers a clean two-ingredient label but relies on one short industry-funded trial with a PS dose below the studied range. Focus Factor hides its nootropic doses in a proprietary blend and contains vinpocetine, an ingredient flagged by the FDA for fetal harm. Alpha Brain has one published trial, but it was conducted in young adults, the current formula differs from the tested version, and the bacopa dose is one-third of the studied amount. MindVault is the closest alternative, trading bacopa for rhodiola and adding B12.

For adults over 50 seeking memory support, the combination of citicoline, bacopa and phosphatidylserine at transparent doses still holds the strongest evidence alignment. None of the four alternatives improves on that specific stack.

Frequently Asked Questions

Is Neuriva better than Harmo Brain?

Not for memory-specific support in adults over 50. Neuriva contains no citicoline and no bacopa. Its phosphatidylserine dose is 100 mg, while most cognitive trials used 300 mg. The only published trial lasted 42 days and was industry-sponsored.

Does Focus Factor have a proprietary blend?

Yes. Focus Factor Original hides its nootropic ingredients in a 641 mg proprietary blend. The exact dose of each ingredient is not listed. Independent analysis suggests the blend is too small to contain effective doses of its key actives.

Why is Alpha Brain tested only in young adults?

The published Solomon et al. (2015) trial enrolled 63 healthy adults aged 18 to 35. There are no published RCTs of Alpha Brain in adults over 50. The current formula also differs from the tested version because vinpocetine was removed.

Can I take MindVault instead of Harmo Brain?

MindVault is the closest alternative. It shares citicoline and phosphatidylserine with Harmo Brain but replaces bacopa with rhodiola and adds B12. For memory-specific concerns, Harmo Brain’s 300 mg bacopa has stronger human data. For broader cognitive support and mental fatigue, MindVault’s rhodiola adds a different mechanism.

Which alternative has the most clinical evidence?

MindVault, because each of its four ingredients has independent peer-reviewed RCTs. Neuriva has one industry-sponsored trial on the finished formula. Alpha Brain has one company-funded trial in young adults. Focus Factor has no published independent RCT on its formula.

Is vinpocetine safe in Focus Factor?

No. The FDA warned in 2019 that vinpocetine may cause fetal harm and miscarriage. The agency advised supplement companies to include safety warnings for pregnant women. Focus Factor still contains vinpocetine without a prominent pregnancy warning on the front label.

Does Neuriva contain citicoline or bacopa?

No. Neuriva Original contains only whole coffee cherry extract and phosphatidylserine. It does not contain citicoline, bacopa monnieri, B12 or any cholinergic ingredient.

What should I look for on a memory supplement label?

Transparent doses with no proprietary blend. Standardized extracts (bacopa at 300 mg with at least 55% bacosides). Third-party testing (USP or NSF). Studied doses matching published RCTs. No vinpocetine, no hidden stimulants, no artificial dyes.

Sources and References

Need help choosing?

RecallPath does not sell supplements. We publish facts for readers over 40.

Email us